Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $17,601 | 871 | 99.2% |
| Education | $141.74 | 16 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $4,061 | 198 | $0 (2024) |
| Novo Nordisk Inc | $1,918 | 120 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,243 | 69 | $0 (2024) |
| Amarin Pharma Inc. | $1,187 | 67 | $0 (2022) |
| Amgen Inc. | $1,146 | 55 | $0 (2024) |
| Lilly USA, LLC | $1,020 | 42 | $0 (2024) |
| Esperion Therapeutics, Inc. | $904.27 | 49 | $0 (2024) |
| Insulet Corporation | $737.39 | 29 | $0 (2024) |
| Corcept Therapeutics | $662.52 | 18 | $0 (2024) |
| ABBVIE INC. | $654.04 | 28 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,677 | 91 | AstraZeneca Pharmaceuticals LP ($779.27) |
| 2023 | $1,938 | 86 | AstraZeneca Pharmaceuticals LP ($250.11) |
| 2022 | $2,489 | 121 | Insulet Corporation ($340.72) |
| 2021 | $1,734 | 93 | Esperion Therapeutics, Inc. ($416.11) |
| 2020 | $1,651 | 96 | AstraZeneca Pharmaceuticals LP ($581.44) |
| 2019 | $2,128 | 116 | AstraZeneca Pharmaceuticals LP ($693.93) |
| 2018 | $2,760 | 146 | AstraZeneca Pharmaceuticals LP ($777.47) |
| 2017 | $2,365 | 138 | AstraZeneca Pharmaceuticals LP ($541.90) |
All Payment Transactions
887 individual payment records from CMS Open Payments — Page 36 of 36
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/25/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKAMET, INVOKANA | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/25/2017 | Orexigen Therapeutics, Inc. | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: OBESITY | ||||||
| 01/19/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.10 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/18/2017 | Horizon Pharma plc | PENNSAID (Drug) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: PENNSAID | ||||||
| 01/18/2017 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $3.92 | General |
| Category: Diabetes | ||||||
| 01/17/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.96 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/11/2017 | Takeda Pharmaceuticals America, Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $11.75 | General |
| Category: Central Nervous System (CNS) | ||||||
| 01/09/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug), BEVESPI AEROSPHERE | Food and Beverage | In-kind items and services | $94.62 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/09/2017 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: Endocrinology | ||||||
| 01/05/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/05/2017 | Lilly USA, LLC | TRADJENTA (Drug), TRULICITY, BASAGLAR | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: Diabetes | ||||||
| 01/03/2017 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 92 | 259 | $41,334 | $20,090 |
| 2022 | 2 | 68 | 210 | $33,820 | $16,544 |
| 2021 | 3 | 89 | 220 | $35,222 | $18,330 |
| 2020 | 4 | 118 | 276 | $38,445 | $15,975 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 57 | 198 | $32,868 | $15,771 | 48.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 24 | 47 | $5,358 | $2,570 | 48.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 14 | $3,108 | $1,749 | 56.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 57 | 190 | $31,540 | $15,269 | 48.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 11 | 20 | $2,280 | $1,275 | 55.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 51 | 165 | $27,390 | $13,732 | 50.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 22 | 22 | $4,070 | $2,833 | 69.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 16 | 33 | $3,762 | $1,765 | 46.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 52 | 150 | $24,900 | $9,642 | 38.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 30 | 90 | $10,260 | $4,658 | 45.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 11 | 11 | $2,035 | $1,228 | 60.3% |
| 99211 | Established patient office or other outpatient visit, typically 5 minutes | Office | 2020 | 25 | 25 | $1,250 | $447.00 | 35.8% |
About James Mclennan, MD PC
James Mclennan, MD PC is a Family Medicine healthcare provider based in Reno, Nevada. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1588760169.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, James Mclennan, MD PC has received a total of $17,743 in payments from pharmaceutical and medical device companies, with $2,677 received in 2024. These payments were reported across 887 transactions from 50 companies. The most common payment nature is "Food and Beverage" ($17,601).
As a Medicare-enrolled provider, Mclennan has provided services to 367 Medicare beneficiaries, totaling 965 services with total Medicare billing of $70,939. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Reno, NV
- Active Since 09/15/2006
- Last Updated 03/18/2009
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1588760169
Products in Payments
- FARXIGA (Drug) $2,532
- Vascepa (Drug) $1,187
- JARDIANCE (Drug) $839.79
- Omnipod (Device) $737.39
- NEXLETOL (Drug) $664.68
- Korlym (Drug) $662.52
- BREZTRI (Drug) $569.77
- Ozempic (Drug) $488.01
- Kerendia (Drug) $473.29
- INVOKANA (Drug) $353.64
- Wegovy (Drug) $351.17
- Saxenda (Drug) $338.57
- MOUNJARO (Drug) $322.50
- BEVESPI AEROSPHERE (Drug) $296.11
- VRAYLAR (Drug) $286.65
- Otezla (Drug) $259.47
- NURTEC ODT (Drug) $254.86
- Trintellix (Drug) $254.19
- Prolia (Biological) $251.05
- XIFAXAN (Drug) $244.94
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Reno
Catherine Mccarthy, Md, MD
Family Medicine — Payments: $52,895
Dr. Jeremy Bearfield, Md, Phd, MD, PHD
Family Medicine — Payments: $22,339
Dr. Michael O'brien, Md, MD
Family Medicine — Payments: $22,320
Dr. Vance Alm, Md, MD
Family Medicine — Payments: $18,168
Bayo Curry-Winchell, Md, MD
Family Medicine — Payments: $12,638
Dr. Suraj Verma, M.d, M.D
Family Medicine — Payments: $12,462